236 related articles for article (PubMed ID: 17194835)
1. Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
El'Garch F; Jeannot K; Hocquet D; Llanes-Barakat C; Plésiat P
Antimicrob Agents Chemother; 2007 Mar; 51(3):1016-21. PubMed ID: 17194835
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Islam S; Oh H; Jalal S; Karpati F; Ciofu O; Høiby N; Wretlind B
Clin Microbiol Infect; 2009 Jan; 15(1):60-6. PubMed ID: 19154484
[TBL] [Abstract][Full Text] [Related]
3. Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
Vogne C; Aires JR; Bailly C; Hocquet D; Plésiat P
Antimicrob Agents Chemother; 2004 May; 48(5):1676-80. PubMed ID: 15105120
[TBL] [Abstract][Full Text] [Related]
4. Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis.
Chuanchuen R; Wannaprasat W; Ajariyakhajorn K; Schweizer HP
Microbiol Immunol; 2008 Aug; 52(8):392-8. PubMed ID: 18667038
[TBL] [Abstract][Full Text] [Related]
5. MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa.
Mao W; Warren MS; Lee A; Mistry A; Lomovskaya O
Antimicrob Agents Chemother; 2001 Jul; 45(7):2001-7. PubMed ID: 11408215
[TBL] [Abstract][Full Text] [Related]
6. Aminoglycoside resistance mechanisms in Pseudomonas aeruginosa isolates from non-cystic fibrosis patients in Thailand.
Poonsuk K; Tribuddharat C; Chuanchuen R
Can J Microbiol; 2013 Jan; 59(1):51-6. PubMed ID: 23391230
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
Hocquet D; Berthelot P; Roussel-Delvallez M; Favre R; Jeannot K; Bajolet O; Marty N; Grattard F; Mariani-Kurkdjian P; Bingen E; Husson MO; Couetdic G; Plésiat P
Antimicrob Agents Chemother; 2007 Oct; 51(10):3531-6. PubMed ID: 17682106
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of adaptive resistance to aminoglycosides of Pseudomonas aeruginosa].
Hocquet D; El Garch F; Vogne C; Plésiat P
Pathol Biol (Paris); 2003 Oct; 51(8-9):443-8. PubMed ID: 14568587
[TBL] [Abstract][Full Text] [Related]
9. Mutations in Gene
Bolard A; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133559
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of MexXY and OpmG in aminoglycoside efflux in Pseudomonas aeruginosa.
Chuanchuen R; Wannaprasat W; Schweizer HP
Southeast Asian J Trop Med Public Health; 2008 Jan; 39(1):115-22. PubMed ID: 18567450
[TBL] [Abstract][Full Text] [Related]
11. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
Wolter DJ; Black JA; Lister PD; Hanson ND
J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
[TBL] [Abstract][Full Text] [Related]
12. Contribution of the MexXY multidrug efflux pump and other chromosomal mechanisms on aminoglycoside resistance in Pseudomonas aeruginosa isolates from canine and feline infections.
Poonsuk K; Chuanchuen R
J Vet Med Sci; 2012 Dec; 74(12):1575-82. PubMed ID: 22813987
[TBL] [Abstract][Full Text] [Related]
13. Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa.
Islam S; Jalal S; Wretlind B
Clin Microbiol Infect; 2004 Oct; 10(10):877-83. PubMed ID: 15373880
[TBL] [Abstract][Full Text] [Related]
14. Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa.
Schurek KN; Marr AK; Taylor PK; Wiegand I; Semenec L; Khaira BK; Hancock RE
Antimicrob Agents Chemother; 2008 Dec; 52(12):4213-9. PubMed ID: 18824604
[TBL] [Abstract][Full Text] [Related]
15. A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and β-lactams in Pseudomonas aeruginosa.
Muller C; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2011 Mar; 55(3):1211-21. PubMed ID: 21149619
[TBL] [Abstract][Full Text] [Related]
16. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides.
Aires JR; Köhler T; Nikaido H; Plésiat P
Antimicrob Agents Chemother; 1999 Nov; 43(11):2624-8. PubMed ID: 10543738
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa.
Hocquet D; Nordmann P; El Garch F; Cabanne L; Plésiat P
Antimicrob Agents Chemother; 2006 Apr; 50(4):1347-51. PubMed ID: 16569851
[TBL] [Abstract][Full Text] [Related]
18. Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7.
Morita Y; Tomida J; Kawamura Y
Microbiology (Reading); 2012 Apr; 158(Pt 4):1071-1083. PubMed ID: 22282519
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of the rplU-rpmA ribosomal protein operon in mexXY-expressing pan-aminoglycoside-resistant mutants of pseudomonas aeruginosa.
Lau CH; Fraud S; Jones M; Peterson SN; Poole K
Antimicrob Agents Chemother; 2012 Oct; 56(10):5171-9. PubMed ID: 22825121
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
Okamoto K; Gotoh N; Nishino T
Antimicrob Agents Chemother; 2001 Jul; 45(7):1964-71. PubMed ID: 11408209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
